Drug Type Gene therapy |
Synonyms VG 202, VG202 |
Target- |
Mechanism Cell death stimulants, Immunologic cytotoxicity |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Liver Cancer | Preclinical | CA | ![]() | - |